Connect with us
96% of the biotech companies are SMEs or micro-SMEs, contributing minimally to the Spanish biotech sector revenues. Large firms, though only 4.1%, account for 37.9% of...
The pharmaceutical industry sees a surge in R&D investment, reaching $145.5 billion last year, 4.5% higher than drug launch budgets in 2022. Deloitte's report on pharmaceutical...
Regarding the priorities of the Spanish health and biotechnology industries, first is the implementation of new tools and technologies, followed by the promotion of the culture...
The company has confirmed that, as a result of its commitment to R&D in oncology, it has achieved a success rate of 37% in its research, compared...
The biopharmaceutical sector has registered an increase of 2.5% in R&D investments in 2020, according to the most recent study conducted by Deloitte. The report reveals...